ENDRA Life Sciences Inc.
NDRA
$5.50
-$0.42-7.10%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 794.00K | 1.81M | 2.06M | 3.23M | 4.75M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 254.70K | 44.30K | 115.30K | 204.20K | 217.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.05M | 1.85M | 2.18M | 3.43M | 4.96M |
|
|
|||||
| Total Current Assets | 1.05M | 1.85M | 2.18M | 3.43M | 4.96M |
| Net Property, Plant & Equipment | 544.00K | 583.40K | 619.00K | 647.30K | 310.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 371.40K | 371.40K | 371.40K | 371.40K | 3.11M |
| Total Assets | 1.96M | 2.81M | 3.17M | 4.45M | 8.38M |
|
|
|||||
| Total Accounts Payable | 252.50K | 282.00K | 223.60K | 269.70K | 279.40K |
| Total Accrued Expenses | 419.00K | 166.40K | 216.10K | 68.90K | 139.10K |
| Short-term Debt | -- | -- | -- | 169.70K | 208.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 128.80K | 128.20K | 126.10K | 96.90K | 187.30K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 800.30K | 576.60K | 565.80K | 605.20K | 814.00K |
|
|
|||||
| Total Current Liabilities | 800.30K | 576.60K | 565.80K | 605.20K | 814.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 169.70K | 208.20K |
| Capital Leases | 396.50K | 429.30K | 461.20K | 487.50K | 49.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 595.90K | 328.60K | 390.70K | 799.30K | 910.60K |
| Total Liabilities | 1.79M | 1.33M | 1.42M | 1.89M | 1.77M |
|
|
|||||
| Common Stock & APIC | 107.47M | 107.17M | 106.23M | 106.00M | 105.89M |
| Retained Earnings | -107.30M | -105.70M | -104.47M | -103.44M | -99.29M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 171.40K | 1.47M | 1.75M | 2.56M | 6.60M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 171.40K | 1.47M | 1.75M | 2.56M | 6.60M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 171.40K | 1.47M | 1.75M | 2.56M | 6.60M |
|
|
|||||